CRAASH Barcelona, accelerating innovation in healthtech

Moebio is the Biocat talent-development initiative to foster entrepreneurship and innovation in the healthcare arena. In 2019, Moebio launched the second edition of its long program CRAASH Barcelona. This initiative is a 12-week course to help research teams from Catalonia and other European countries successfully launch innovations to market in the fields of medical devices, diagnostics and e-health and digital health. 

CRAASH Barcelona is a bootcamp program of EIT Health, the largest European health consortium, and is organized by Biocat in collaboration with CIMIT. The teams transfer their research to market, guided by expert mentors from CIMIT (Boston), the most experienced accelerator in the world. In 20 years, CIMIT has successfully accelerated more than 600 healthtech projects, doubled the product-to-market rate and helped raise over $1 billion in additional funding.  

The CRAASH Barcelona teams validate the problems and solutions for their products and how they fit the market in some of the most important healthcare ecosystems in Europe and the United States. In July and September, they visited the Medicen (Paris) and Yes!Delft (Delft) ecosystems, respectively. In November, they traveled to Boston to do some networking and validate their projects at Device Talks, where they had the opportunity to pitch to potential investors and partners.

Kick-off of CRAASH Barcelona 2019.

Eight cutting-edge projects

A total of 65 projects from 21 countries applied to the second edition of CRAASH Barcelona. Eight were selected:

Luminate Medical: a company from the National University of Ireland, Galway that is developing a portable electric device to end hair loss caused by chemotherapy painlessly and without risk of infection.

NeedleSafe: technology from Pompeu Fabra University to prevent the risk of infections after biopsy procedures by using a silver-coated biopsy needle that releases silver ions that have an antibacterial effect.

Smiletronix: a solution from British company Smiletronix, currently located in Barcelona, that offers users a regular, affordable dental check-up from home, using the Internet of Things (IOT) and artificial intelligence.

Smart Flora: a mobile app from British company Smart Flora, currently located in Barcelona, to alleviate patients’ intestinal discomfort with personalized plans for food and nutritional supplements, based on scientific research. Users receive probiotic tips based on their symptoms and food recommendations based on their microbiome profile, analyzed in the laboratory beforehand.

Aniling: a solution developed by Catalan company Aniling that simultaneously analyzes the patient’s genome and epigenome to advance research and clinical use of personalized medicine.

Flomics Biotech: a liquid biopsy tool developed by Barcelona-based company Flomics Biotech that combines analysis of ribonucleic acid (RNA) circulating in the blood and machine learning algorithms for screening, diagnosis, prognosis, monitoring and stratification of patients with complex diseases like colorectal cancer.

Nima: a project from Charite University Hospital Berlin to supply low-cost, reliable surgical knots that are easy to use, minimizing the risk for patients in surgery or emergency situations, including war zones and humanitarian crises.

SeizeIT: a device developed by UCB Pharma (Belgium) worn discreetly in the patient’s ear that senses various types of signals to detect epileptic convulsions.

Levitate Medical: a laparoscopic surgical device, developed in Ireland that gives surgeons a more effective, less invasive way to treat Pelvic Organ Prolapse, a debilitating condition that affects millions of women.

Fine Birth: a device from Granada-based company Innitius that diagnoses false threatened preterm labor in real time with a fast, low-cost test.